Court Reopens Teva, Novartis Spat Over Herpes Drug

Law360, New York (July 16, 2007, 12:00 AM EDT) -- A U.S. District Court judge has revived Teva Pharmaceutical Industries Ltd.'s case challenging Novartis AG's patents for genital herpes drug Famvir.

Judge Jose L. Linares of the U.S. District Court for the District of New Jersey reopened the case Friday following the U.S. Court of Appeals for the Federal Circuit's decision to vacate his dismissal of Teva's case.

The Israel-based generic drug maker had sought declaratory judgment that its 2004 Abbreviated New Drug Application filed with the U.S. Food and Drug Administration to sell famciclovir, the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.